Jubilant Ingrevia up 2% USFDA issues Zero observations for Bharuch unit
The market capitalisation of Jubilant Ingrevia is Rs 8,383.76 crore, according to Bombay Stock Exchange (BSE)28-06-2024
28-06-2024
Jubilant Ingrevia Ltd - 543271 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Communication from United States Food and Drug Administration (USFDA)27-06-2024
Jubilant Ingrevia Ltd - 543271 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate.26-06-2024
Jubilant Ingrevia Ltd - 543271 - Intimation of Repayment of Commercial Paper (CP)
Intimation of Repayment of commercial Paper26-06-2024
Jubilant Ingrevia Ltd - 543271 - Certificate Under Chapter XVII Of SEBI Operational Circular Dated 10Th August 2021
certificate under Chapter XVII of SEBI Operational Circular Dated 10th August 202126-06-2024
Jubilant Ingrevia Ltd - 543271 - Disclosure under Regulation 30A of LODR
Appointment of Chief Financial Officer26-06-2024
Jubilant Ingrevia Ltd - 543271 - Intimation of Repayment of Commercial Paper (CP)
Intimation of Redemption of Commercial Paper25-06-2024
Jubilant Ingrevia Ltd - 543271 - Certificate Under Chapter XVII Of SEBI Operational Circular Dated 10Th August 2021
Certificate Under Chapter XVII of SEBI Operational Circular dated August 10, 202125-06-2024
Jubilant Ingrevia Ltd - 543271 - Intimation Of Record Date For Maturity Of Commercial Paper
Intimation of Record date25-06-2024
Jubilant Ingrevia Ltd - 543271 - Announcement under Regulation 30 (LODR)-Issue of Securities
Issue of Commercial Paper25-06-2024